tiprankstipranks
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Income Statement

Compare
312 Followers

Evaxion Biotech Income Statement

Last quarter (Q1 2024), Evaxion Biotech's total revenue was $50.88K, an increase of Infinity% from the same quarter last year. In Q1, Evaxion Biotech's net income was $1.19M. See Evaxion Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 73.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 72.89K$ -571.32K$ -343.45K$ -105.72K$ -80.98K
Operating Expenses
$ 22.25M$ 25.26M$ 25.83M$ 16.57M$ 10.86M
Depreciation and Amortization
$ 615.95K$ 571.32K$ 343.45K$ 105.72K$ 80.98K
EBITDA
$ -21.40M$ -22.58M$ -24.17M$ -16.46M$ -11.90M
Operating Income
$ -22.20M$ -25.26M$ -25.83M$ -16.57M$ -10.86M
Other Income/Expenses
$ -718.00K$ 1.32M$ 1.12M$ -7.00K$ -1.16M
Pretax Income
$ -22.91M$ -23.94M$ -24.71M$ -16.57M$ -12.02M
Net Income
$ -22.13M$ -23.17M$ -24.53M$ -15.02M$ -11.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.62$ -9.80$ -12.58$ -9.27$ -6.91
Diluted EPS
$ -1.62$ -9.80$ -12.58$ -9.27$ -6.91
Weighted Average Shares Outstanding
13.67M 2.36M 1.95M 1.62M 1.62M
Weighted Average Shares Outstanding (Diluted)
13.67M 2.36M 1.95M 1.62M 1.62M
Currency in USD

Evaxion Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis